Ovarian Cancer: Recurrence
SHARE

Ovarian Cancer: Recurrence

Many women who've been treated for ovarian cancer will have a recurrence within five years ... there are many treatment options, some very new.

SN Local - Explore expertise and community near you:

Recurrence: Managing Recurrence

SEE MORE   
Recurrence

Dealing with Recurrence

Dr. Beth Karlan
UCLA Medical Center
Overview

Changing Landscape Of Ovarian Cancer Treatment: PARP Inhibitor Drugs Withdrawn For Some Indications

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein

Recurrence: Managing Recurrence

Recurrence: What Are The Options When the Cancer Returns?

SEE MORE   
Recurrence

When Ovarian Cancer Comes Back-- The Standard of Care Treatment

Dr. Rebecca Arend
University of Alabama-Birmingham
Recurrence

When Ovarian Cancer Becomes Resistant to Chemotherapy, New Drug Elahere Shows Promise

Dr. Muneeb Niazi
Recurrence

Recurrent Ovarian Cancer Treatment - Is Your Disease "Platinum-Sensitive"?

Dr. Oliver Dorigo
Stanford University Medical Center
Recurrence

Women with Recurrent Ovarian Cancer Are Living Longer on PARP Inhibitors

Dr. Ursula Matulonis
Dana-Farber Cancer Institute
Recurrence

Fighting "Platinum Resistant" Ovarian Cancer

Dr. Bobbie Rimel
Cedars-Sinai Medical Center

Recurrence: What Are The Options When the Cancer Returns?

Recurrence: PARP Inhibitors: An Important Treatment on the Cutting Edge

Dr. Oliver Dorigo

Stanford University Medical Center
Recurrence

Weighing the Benefits of PARP Inhibitors

Dr. Emese Zsiros
Roswell Park Comprehensive Cancer Center
Recurrence

What's it Like to Take a PARP Inhibitor?

Dr. Rebecca Arend
University of Alabama-Birmingham
Recurrence

Who Can Receive PARP Inhibitors?

Dr. Oliver Dorigo
Stanford University Medical Center
Recurrence

Managing Side Effects: Which PARP Inhibitor Is Right For Me?

Dr. Oliver Dorigo
Stanford University Medical Center
Recurrence

Costs and Barriers to Getting PARP Inhibitors

Dr. Ursula Matulonis
Dana-Farber Cancer Institute
Recurrence

When PARP Inhibitors Stop Working: Testing Combinations

Dr. Ursula Matulonis
Dana-Farber Cancer Institute

Dr. Oliver Dorigo

Stanford University Medical Center
Recurrence

Weighing the Benefits of PARP Inhibitors

Dr. Emese Zsiros
Roswell Park Comprehensive Cancer Center
Recurrence

What's it Like to Take a PARP Inhibitor?

Dr. Rebecca Arend
University of Alabama-Birmingham
Recurrence

Who Can Receive PARP Inhibitors?

Dr. Oliver Dorigo
Stanford University Medical Center
Recurrence

Managing Side Effects: Which PARP Inhibitor Is Right For Me?

Dr. Oliver Dorigo
Stanford University Medical Center
Recurrence

Costs and Barriers to Getting PARP Inhibitors

Dr. Ursula Matulonis
Dana-Farber Cancer Institute
Recurrence

When PARP Inhibitors Stop Working: Testing Combinations

Dr. Ursula Matulonis
Dana-Farber Cancer Institute

Recurrence: My Cancer's Come Back. Should I Try A Clinical Trial?

Recurrence

The Option of Clinical Trial

Dr. Dana Chase
UCLA

Why I'd Choose a Clinical Trial For Myself

Dr. Ben Neel
NYU Perlmutter Cancer Center

Clinical Trials Can Be Life-Saving

Dr. Beth Karlan
UCLA Medical Center
Later Stage

Clinical Trials and What Statistics Really Mean

Dr. Scott Strome
University of Maryland
Recurrence

Promising Immunotherapy Trials for Ovarian Cancer

Dr. Kunle Odunsi
Roswell Park Comprehensive Cancer Center
Recurrence

Ovarian Cancer - The Importance of Increasing Diversity in Clinical Trials

Dr. Dana Chase
UCLA
Recurrence

The Option of Clinical Trial

Dr. Dana Chase
UCLA

Why I'd Choose a Clinical Trial For Myself

Dr. Ben Neel
NYU Perlmutter Cancer Center

Clinical Trials Can Be Life-Saving

Dr. Beth Karlan
UCLA Medical Center
Later Stage

Clinical Trials and What Statistics Really Mean

Dr. Scott Strome
University of Maryland
Recurrence

Promising Immunotherapy Trials for Ovarian Cancer

Dr. Kunle Odunsi
Roswell Park Comprehensive Cancer Center
Recurrence

Ovarian Cancer - The Importance of Increasing Diversity in Clinical Trials

Dr. Dana Chase
UCLA

Recurrence: Immunotherapy as a Weapon Against Recurrence

Dr. Emese Zsiros

Roswell Park Comprehensive Cancer Center
Recurrence

Immunotherapy in Recurrence

Dr. Kunle Odunsi
Roswell Park Comprehensive Cancer Center
Recurrence

Overcoming Hurdles in Immunotherapy

Dr. Kunle Odunsi
Roswell Park Comprehensive Cancer Center
Recurrence

Promising Immunotherapy Trials for Ovarian Cancer

Dr. Kunle Odunsi
Roswell Park Comprehensive Cancer Center
Recurrence

Exciting Developments in Immunotherapy for Ovarian Cancer

Dr. David Cibula
First Faculty of Medicine - Charles University

Dr. Emese Zsiros

Roswell Park Comprehensive Cancer Center
Recurrence

Immunotherapy in Recurrence

Dr. Kunle Odunsi
Roswell Park Comprehensive Cancer Center
Recurrence

Overcoming Hurdles in Immunotherapy

Dr. Kunle Odunsi
Roswell Park Comprehensive Cancer Center
Recurrence

Promising Immunotherapy Trials for Ovarian Cancer

Dr. Kunle Odunsi
Roswell Park Comprehensive Cancer Center
Recurrence

Exciting Developments in Immunotherapy for Ovarian Cancer

Dr. David Cibula
First Faculty of Medicine - Charles University
>

SN Local - Explore Ovarian Cancer expertise and community near you:

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.